AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's Illness

Published September 9, 2020 at 2:32 PM CDT

Facebook
Twitter
LinkedIn
Email

NPR's Noel King talks to Paul Offit of the Vaccine Education Center at Children's Hospital of Philadelphia, about the coronavirus vaccine trial developed by AstraZeneca and the University of Oxford.

AstraZeneca Pauses COVID-19 Vaccine Trial Due To Volunteer's Illness

Subscribe to the Daily Digest, your five minute read to know what's happening in Iowa and around the country.